跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 74,672 条关于
“sodium-glucose cotransporter 2”
全部
74,672
临床试验
50,434
药物
8,395
机构
1,419
资讯
14,424
2年前
Study Shows SGLT2 Inhibitors Improve Renal Function in Non-Diabetic CKD Patients
去年
Dapagliflozin Approved by FDA to Reduce Cardiovascular and Renal Risks in CKD Patients
2年前
SGLT-2 Inhibitors Linked to Reduced Dementia Risk in Type 2 Diabetes Study
2个月前
Daewoong's Envlo Becomes First Korean SGLT-2 Inhibitor to Enter MENA Market in ₩145.2 Billion Deal
去年
SGLT2 Inhibitors Show Promise in Managing Chronic Kidney Disease in Real-World Settings
11个月前
SGLT-2 Inhibitors Show 11% Reduction in Autoimmune Disease Risk in Large Korean Study
3年前
Targeting the Endothelin A Receptor in IgA Nephropathy: A New Therapeutic Approach
去年
Empagliflozin May Slow Diabetic Retinopathy Progression in Type 2 Diabetes
去年
CDSCO Approves Phase III Trials for Two Novel Cardiovascular Fixed-Dose Combinations
去年
GLP-1 Receptor Agonists Prescriptions Rise for Off-Label Use in Type 1 Diabetes
第 1 页，共 1443 页
上一页
下一页
